GEMMA ANDERSON: Open Payments
NPI 1124524780 · ARLINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,808 in 72 payments from 31 companies in 2025. Trend: 2023 $548 · 2024 $1,571 · 2025 $1,808
Food & beverage: $1,743Education: $65
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $268 |
| Janssen Biotech, Inc. | 6 | $145 |
| ARRAY BIOPHARMA INC | 5 | $118 |
| ABBVIE INC. | 5 | $117 |
| Incyte Corporation | 2 | $89 |
| PFIZER INC. | 4 | $79 |
| AstraZeneca Pharmaceuticals LP | 3 | $75 |
| Merck Sharp & Dohme LLC | 3 | $74 |
| BeOne Medicines USA, Inc. | 3 | $70 |
| GlaxoSmithKline, LLC. | 3 | $67 |
Products named: PLUVICTO, BRAFTOVI, Fabhalta, BESREMI, Venclexta, Nubeqa, XALKORI, ENHERTU.
Industry payments across TX — which companies pay providers there.
